Back to Search Start Over

Advantages of total parathyroidectomy in patients with secondary hyperparathyroidism induced by end stage renal disease.

Authors :
Iorga C
Iorga CR
Andreiana I
Bengulescu I
Constantin T
Strambu V
Source :
Frontiers in endocrinology [Front Endocrinol (Lausanne)] 2023 Nov 22; Vol. 14, pp. 1191914. Date of Electronic Publication: 2023 Nov 22 (Print Publication: 2023).
Publication Year :
2023

Abstract

Introduction: Secondary hyperparathyroidism, as a result of chronic kidney disease could be treated medically or surgically. When pharmacotherapy fails, patients undergo surgery - parathyroidectomy, the curative treatment of secondary hyperparathyroidism (SHPT). There are currently 3 accepted surgical techniques, each with supporters or opponents - total parathyroidectomy, subtotal parathyroidectomy and parathyroidectomy with immediate autotransplantation.<br />Methods: In this paper we described our experience on a series of 160 consecutive patients diagnosed with secondary hyperparathyroidism who underwent surgery, in 27 cases it was totalization of the intervention (patients with previously performed subtotal parathyroidectomy or with supernumerary glands and SHPT recurrence). We routinely perform total parathyroidectomy, the method that we believe offers the best results.<br />Results: The group of patients was studied according to demographic criteria, paraclinical balance, clinical symptomatology, pre- and postoperative iPTH (intact parathormone) values, SHPT recurrence, number of reinterventions. In 31 cases we found gland ectopy and in 15 cases we discovered supernumerary parathyroids. A percentage of 96.24% of patients with total parathyroidectomy did not show recurrence.<br />Discussions: After analyzing the obtained results, our conclusion was that total parathyroidectomy is the intervention of choice for patients suffering from secondary hyperparathyroidism when pharmacotherapy fails in order to prevent recurrence of the disease and to correct the metabolic parameters.<br />Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.<br /> (Copyright © 2023 Iorga, Iorga, Andreiana, Bengulescu, Constantin and Strambu.)

Details

Language :
English
ISSN :
1664-2392
Volume :
14
Database :
MEDLINE
Journal :
Frontiers in endocrinology
Publication Type :
Academic Journal
Accession number :
38075043
Full Text :
https://doi.org/10.3389/fendo.2023.1191914